A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
10.1007/s11523-023-00962-w
Saved in:
Main Authors: | Chee, Cheng E, Ooi, Melissa, Lee, Soo-Chin, Sundar, Raghav, Heong, Valerie, Yong, Wei-Peng, Ng, Chin Hin, Wong, Andrea, Lim, Joline SJ, Tan, David SP, Soo, Ross, Tan, Joshua TC, Yang, Song, Thura, Min, Al-Aidaroos, Abdul Qader, Chng, Wee Joo, Zeng, Qi, Goh, Boon-Cher |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Language: | English |
Published: |
SPRINGER
2023
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/239257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014) -
PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
by: Liu, H., et al.
Published: (2014) -
Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
by: Guo, Ke, et al.
Published: (2021) -
PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress
by: Shi, Yin, et al.
Published: (2022) -
IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma
by: Chong, Phyllis SY, et al.
Published: (2020)